A phase I dose escalation of hydroxyurea (HU) in addition to continuous infusion 5-fluorouracil (5FU) in patients with advanced colorectal cancer

被引：0
|
作者：
Last, K [1 ]
Lofts, FJ [1 ]
Thompson, F [1 ]
Mansi, JL [1 ]
机构：
[1] St Georges Healthcare NHS Trust, Dept Med Oncol, London, England
来源：
EUROPEAN JOURNAL OF CANCER | 1998年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PP71
引用
收藏
页码：S14 / S14
页数：1
相关论文
共 50 条
  • [1] Combined radiotherapy, 5-Fluorouracil (5FU) continuous infusion and weekly Oxaliplatin in advanced rectal cancer: Phase I study
    Francois, Eric D.
    Ychou, Marc
    Ducreux, Michel
    Bertheault-Cvitkovic, Frederique
    Giovannini, Marc
    Conroy, Thierry
    Lemansk, Claire
    Thomas, Oliver
    Mari, Veronique
    ANNALS OF ONCOLOGY, 2004, 15 : 96 - 97
  • [2] CONTINUOUS 5-FLUOROURACIL (5FU) INFUSION IN CARCINOMA OF THE PANCREAS - A PHASE-II STUDY
    HANSEN, R
    QUEBBEMAN, E
    RITCH, P
    CHITAMBAR, C
    ANDERSON, T
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1988, 295 (02): : 91 - 93
  • [3] Schedule dependency of 5-fluorouracil (5FU) chemotherapy in patients with advanced colorectal cancer: A systematic review\ .
    Barrajon, E
    Esquerdo, G
    Lopez, A
    Llorca, C
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 161S - 161S
  • [4] Third line oxaliplatin with leucovorin (LV) and continuous infusion 5-fluorouracil (5FU) in metastatic colorectal cancer.
    Abón, G
    Muñoz, A
    Rubio, I
    Mañé, JM
    Ferreiro, J
    Fernández, R
    Fuente, N
    López-Argumedo, G
    Barceló, R
    Vivanco, GL
    ANNALS OF ONCOLOGY, 2000, 11 : 48 - 49
  • [5] TRIAL BASED ON BIOCHEMICAL MODULATION OF 5 FLUOROURACIL (5FU) BY DAILY SEQUENTIAL HYDROXYUREA (HU) IN COLORECTAL-CANCER
    WALSH, C
    SPEYER, JL
    WERNZ, JC
    BLUM, RH
    MUGGIA, FM
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1985, 26 (MAR): : 168 - 168
  • [6] Phase I study of weekly oxaliplatin (OXA)+5-fluorouracil continuous infusion (FU CI) in patients (pts) with advanced colorectal cancer (CRC).
    Pasetto, LM
    Lonardi, S
    Sartor, L
    Brandes, AA
    Sileni, VC
    Caroti, C
    D'Amico, M
    Gallo, L
    Monfardini, S
    Aschele, C
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 311S - 311S
  • [7] Does the dose of leucovorin (LV) matter with 5-fluorouracil (5FU) in colorectal cancer (CRC)?
    Biagi, James Joseph
    Coakley, Nadia
    Earle, Craig
    Erlichman, Charles
    Fields, Anthony L. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [8] Phase II study of oxaliplatin (OHP) and protracted 5-fluorouracil (5FU) infusion in pretreated metastatic colorectal cancer (MCRC) patients
    Mini, E
    Pinto, C
    Angelelli, B
    Dentico, P
    Piana, E
    Nobili, S
    Gentile, AL
    Scicolone, S
    Mazzei, T
    Martoni, A
    ANNALS OF ONCOLOGY, 2000, 11 : 73 - 73
  • [9] Evaluating 5FU plasma level in colorectal cancer chemotherapy patients through continuous 5FU infusion
    Sakuyama, Naoki
    Sato, Tsuyoshi
    Kishine, Kenji
    Nagayasu, Kiichi
    Nakatani, Akinori
    Kitajima, Masayuki
    ANNALS OF ONCOLOGY, 2022, 33 : S542 - S542
  • [10] LEVELS OF 5-FLUOROURACIL (5FU) IN PLASMA OF PATIENTS TREATED BY DRUG INFUSION
    HILLCOAT, BL
    MCCULLOCH, PB
    FIGUEREDO, A
    ROSENFELD, J
    KAWAI, M
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1976, 17 (MAR): : 199 - 199
12345